Immediate Impact

3 from Science/Nature 73 standout
Sub-graph 1 of 20

Citing Papers

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
Diffuse Large B-Cell Lymphoma
2021 Standout
3 intermediate papers

Works of A. Schilf being referenced

Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin’s lymphoma
2001
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
1996

Author Peers

Author Last Decade Papers Cites
A. Schilf 79 95 171 358 7 487
J Lokich 18 87 152 458 15 561
A. Fandi 47 107 204 290 7 466
Terence Rugg 72 37 257 290 5 469
Swee‐Peng Yap 55 58 251 281 9 519
Benjamin C. Garden 16 78 105 280 13 519
N. Anderson 39 147 99 240 18 468
Elisabetta Alafaci 24 183 149 465 7 571
Muir Cs 51 182 137 185 8 523
Yuzhi Lu 29 98 150 288 8 484
Virag Dandekar 113 165 151 233 6 520

All Works

Loading papers...

Rankless by CCL
2026